Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

August 05, 2016

AstraZeneca Pharmaceuticals LP et al v. Mylan Institutional LLC

Track this case

Case Number:

1:16-cv-00669

Court:

Delaware

Nature of Suit:

Patent

Judge:

Richard G. Andrews

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 08, 2016

    AstraZeneca Says Mylan Can't Sell Cancer Generic Till 2019

    AstraZeneca Pharmaceuticals LP on Friday slapped Mylan Institutional LLC with a Delaware federal suit seeking to block Mylan from selling a generic version of the breast cancer drug Faslodex just a month after allowing Sandoz Inc. to pursue its own generic form.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login